SE8003122L - Kinazolinderivat med antihypertensiv aktivitet - Google Patents

Kinazolinderivat med antihypertensiv aktivitet

Info

Publication number
SE8003122L
SE8003122L SE8003122A SE8003122A SE8003122L SE 8003122 L SE8003122 L SE 8003122L SE 8003122 A SE8003122 A SE 8003122A SE 8003122 A SE8003122 A SE 8003122A SE 8003122 L SE8003122 L SE 8003122L
Authority
SE
Sweden
Prior art keywords
derivatives
amino
compounds
piperazino
antihypertensive activity
Prior art date
Application number
SE8003122A
Other languages
English (en)
Other versions
SE435061B (sv
Inventor
S F Campbell
G Fiars
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10504770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8003122(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of SE8003122L publication Critical patent/SE8003122L/sv
Publication of SE435061B publication Critical patent/SE435061B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8003122A 1979-04-25 1980-04-24 4-amino-6,7-dialkoxikinazolinforening och farmaceutisk beredning for behandling av hypertension SE435061B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914431 1979-04-25

Publications (2)

Publication Number Publication Date
SE8003122L true SE8003122L (sv) 1980-10-26
SE435061B SE435061B (sv) 1984-09-03

Family

ID=10504770

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8003122A SE435061B (sv) 1979-04-25 1980-04-24 4-amino-6,7-dialkoxikinazolinforening och farmaceutisk beredning for behandling av hypertension

Country Status (33)

Country Link
US (1) US4279910A (sv)
JP (1) JPS55145684A (sv)
KR (1) KR830002567B1 (sv)
AR (1) AR224400A1 (sv)
AT (1) AT373596B (sv)
BE (1) BE882967A (sv)
CA (1) CA1132558A (sv)
CH (1) CH642076A5 (sv)
CS (1) CS209950B2 (sv)
DD (1) DD150202A5 (sv)
DE (1) DE3015676A1 (sv)
DK (1) DK121080A (sv)
EG (1) EG14651A (sv)
ES (1) ES8101588A1 (sv)
FI (1) FI64592C (sv)
FR (1) FR2455042A1 (sv)
GB (1) GB2049683B (sv)
GR (1) GR68049B (sv)
HU (1) HU184747B (sv)
IE (1) IE49705B1 (sv)
IL (1) IL59900A (sv)
IT (1) IT1141490B (sv)
LU (1) LU82394A1 (sv)
NL (1) NL182563C (sv)
NO (1) NO152508C (sv)
NZ (1) NZ193511A (sv)
PH (1) PH15156A (sv)
PL (1) PL121470B1 (sv)
PT (1) PT71139A (sv)
SE (1) SE435061B (sv)
SU (1) SU915804A3 (sv)
YU (1) YU41709B (sv)
ZA (1) ZA802488B (sv)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
IE49705B1 (en) 1985-11-27
ZA802488B (en) 1981-08-26
IT8021598A0 (it) 1980-04-23
FI801306A7 (fi) 1980-10-26
FR2455042A1 (fr) 1980-11-21
PH15156A (en) 1982-08-24
PL121470B1 (en) 1982-05-31
GR68049B (sv) 1981-10-29
BE882967A (fr) 1980-10-24
SU915804A3 (en) 1982-03-23
NO152508C (no) 1985-10-09
HU184747B (en) 1984-10-29
KR830002758A (ko) 1983-06-30
EG14651A (en) 1985-03-31
IE800827L (en) 1980-10-25
ATA218980A (de) 1983-06-15
ES490867A0 (es) 1980-12-16
PL223755A1 (sv) 1981-02-13
CH642076A5 (de) 1984-03-30
YU113180A (en) 1983-02-28
NZ193511A (en) 1982-03-30
IT1141490B (it) 1986-10-01
FI64592C (fi) 1983-12-12
IL59900A (en) 1983-11-30
NO152508B (no) 1985-07-01
FI64592B (fi) 1983-08-31
GB2049683A (en) 1980-12-31
FR2455042B1 (sv) 1983-05-20
IL59900A0 (en) 1980-06-30
AR224400A1 (es) 1981-11-30
NO801196L (no) 1980-10-27
DE3015676A1 (de) 1980-11-13
CA1132558A (en) 1982-09-28
YU41709B (en) 1987-12-31
KR830002567B1 (ko) 1983-11-14
ES8101588A1 (es) 1980-12-16
JPS5738591B2 (sv) 1982-08-16
NL182563C (nl) 1988-04-05
PT71139A (en) 1980-05-01
JPS55145684A (en) 1980-11-13
SE435061B (sv) 1984-09-03
US4279910A (en) 1981-07-21
LU82394A1 (fr) 1980-07-31
DD150202A5 (de) 1981-08-19
AT373596B (de) 1984-02-10
NL182563B (nl) 1987-11-02
DK121080A (da) 1980-10-26
NL8002387A (nl) 1980-10-28
CS209950B2 (en) 1981-12-31
GB2049683B (en) 1983-01-26

Similar Documents

Publication Publication Date Title
US3609152A (en) Certain 2-amino-3,4-dihydrogen-inazolin-4-ones and 4-thiones
RU2001124816A (ru) Производные хиназолина в качестве ингибиторов ангиогенеза
BRPI0209216B8 (pt) derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos
GB1199768A (en) Nitrogen Heterocycles and process for their preparation
ATE116310T1 (de) Benzo(5,6)cycloheptapyridine, zusammensetzungen und verwendung.
DE3773660D1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
ES2010091A6 (es) Un metodo para preparar compuestos analogos a nucleosidos didesoxicarbociclicos.
ES418612A1 (es) Procedimiento para preparar derivados de 2-amino y 4-amino-quinazolina.
SE8106060L (sv) Kvaternera spiroammoniumhalider och forfarande for framstellning av n-(2-pyrimidinyl)piperazinylalkylazaspiroalkandioner
DK0733051T3 (da) Bicykliske, heterocykliske forbindelser som neurokinin A-antagonister
DK144685A (da) Substituerede benzopyraner, fremgangsmaader til fremstilling deraf samt deres anvendelse i laegemidler
ES8701752A1 (es) Un procedimiento para preparar derivados de bencimidazol
DE3586649D1 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
ES8900138A1 (es) Un procedimiento para la preparacion de derivados de piperazinilo 1-4-disustituidos.
SE8003122L (sv) Kinazolinderivat med antihypertensiv aktivitet
ES555013A0 (es) Un procedimiento para preparar compuestos heterociclicos nitrogenados.
GB1495665A (en) Pyrimidines
ES8604185A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina.
DK154082C (da) Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK42481A (da) Fremgangsmaade til fremstilling af piperazinderivater af theophyllin
US3738985A (en) Certain 3-(3-amino-2-benzoyloxypropyl)-4(3h)-quinazolinones
KR920009826A (ko) 헤테로사이클로 치환된 피페라지노 알킬벤즈옥사진 및 피페라지노알킬 벤조티아진 화합물과 이들의 제조방법 및 이 화합물들을 포함하는 약제
NO872982L (no) Nye tetracykliske indolderivater.
FR2642758B1 (fr) Derives de pyrimidine,2-(4-((alpha)-heteroaryl-(alpha) aryl-((alpha)-alkyl)-methoxy)-butyl)-1-piperazinyl), avec activite serotoninergique
EP0461681A3 (en) Use of quinazolines in the preparation of a medicament for treating and preventing ischemic cardiac disease or arrhythmia

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8003122-2

Effective date: 19900411

Format of ref document f/p: F